3,646 result(s) found
Spotify Tips for People Who Like to Listen to Whole Albums
https://www.wired.com/story/how-to-get-spotify-to-play-whole-albums/
May 26, 2024 - Spotify favors serving up algorithmically curated playlists instead of complete albums. If you love a long-player, here are some tips to regain control of your listening sessions.
0
Yielding 5%, Is Ford Stock an Excellent Dividend Stock for Passive Income Investors?
https://www.fool.com/investing/2024/05/25/yielding-5-is-ford-stock-an-excellent-buy-for-pass/?source=iedfolrf0000001
May 25, 2024 - Ford Motor Company is investing aggressively to ramp up the production of electric vehicles while harvesting profits from legacy car production.
0
Here's What Happens When You Don't Sign Up for Medicare On Time
https://www.fool.com/retirement/2024/05/25/heres-what-happens-when-you-dont-sign-up-for-medic/?source=iedfolrf0000001
May 25, 2024 - Delaying your Medicare enrollment too long could have serious consequences.
0
Is It Too Late to Buy NuScale Power Stock?
https://www.fool.com/investing/2024/05/25/is-it-too-late-to-buy-nuscale-power-stock/?source=iedfolrf0000001
May 25, 2024 - NuScale Power is up over 150% in the last three months. But the truth is that it might still be too early to buy the stock for many investors.
0
Novo Nordisk once weekly insulin fails to get thumbs up from majority of FDA advisors
https://seekingalpha.com/news/4110352-novo-nordisk-once-weekly-insulin-fails-get-thumbs-up-majority-fda-advisors?source=feed_sector_healthcare
May 24, 2024 - FDA advisory panel expresses concerns about the risks of Novo Nordisk's once-weekly insulin icodec outweighing the benefits. Read more here.
0
Ross Stores (ROST) Q1 Earnings & Sales Beat Estimates, Up Y/Y
https://www.zacks.com/stock/news/2278947/ross-stores-rost-q1-earnings-sales-beat-estimates-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2278947
May 24, 2024 - Ross Stores (ROST) reports solid first-quarter fiscal 2024 results on gains from customers' favorable response to quality and other strategies.
0
Aflac (AFL), Nayya Team Up to Ease Clients' Claim Experience
https://www.zacks.com/stock/news/2278928/aflac-afl-nayya-team-up-to-ease-clients-claim-experience?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2278928
May 24, 2024 - Aflac (AFL) joins forces with Nayya, whose medical claims integration solution will be put to use to ease claims experience and result in the higher utilization of the insurer's supplemental health benefits.
0
Apellis Pharma up on phase 2 data for kidney disease treatment pegcetacoplan
https://seekingalpha.com/news/4110307-apellis-pharma-up-phase-2-data-kidney-disease-treatment-pegcetacoplan?source=feed_sector_healthcare
May 24, 2024 - Pegcetacoplan, an investigational drug from Apelli, shows promising results in reducing disease activity in patients with glomerulopathy. Read more here.
0
Viasat (VSAT), Azercosmos Team Up to Boost Satellite Communication
https://www.zacks.com/stock/news/2278893/viasat-vsat-azercosmos-team-up-to-boost-satellite-communication?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2278893
May 24, 2024 - Azercosmos opts to leverage Viasat's (VSAT) satellite services portfolio to deliver robust connectivity for various industries, including agriculture, mining, utilities, energy and more.
0
Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
https://www.zacks.com/stock/news/2278892/verastem-vstm-up-on-upbeat-early-pancreatic-cancer-study-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2278892
May 24, 2024 - Verastem (VSTM) gains 57% post-market on achieving a confirmed partial response in 83% of first-line patients treated with novel combo therapy in the initial cohort of its phase I/II pancreatic cancer study.
0